Gan & Lee Pharmaceuticals

Pharmaceuticals, Tongzhou District, China, 1001-5000 Employees

ganlee.com

  • facebook
  • twitter
  • LinkedIn

Who is GAN & LEE PHARMACEUTICALS

Founded in 1998, Gan & Lee Pharmaceuticals has successfully developed the first Chinese domestic insulin analog. The company has become one of the main suppliers of insulin in China and n...

Read More

map
  • Tongzhou District, China Headquarters: Tongzhou District, China
  • 1998 Date Founded: 1998
  • 1001-5000 Employees: 1001-5000
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from GAN & LEE PHARMACEUTICALS

Gan & Lee Pharmaceuticals Org Chart and Mapping

Employees

Tazrina Alrazi

Senior Medical Director

Kimberly Lazaroff

Associate Director, Clinical Operations

Wenmin Chen

R&D Director at Preclinical Drug Discovery

Gary Furda

Vice President and Chief Operating Officer

Carolyn Starcher

Clinical Trial Associate

Maria Genovese

Associate Director, Global Program Management

Jia Lu

Executive Director, Head of Global Clinical Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Gan & Lee Pharmaceuticals

Answer: Gan & Lee Pharmaceuticals's headquarters are located at Tongzhou District, China,

Answer: Gan & Lee Pharmaceuticals's official website is https://ganlee.com

Answer: Gan & Lee Pharmaceuticals's SIC: 2834

Answer: Gan & Lee Pharmaceuticals's NAICS: 325412

Answer: Gan & Lee Pharmaceuticals has 1001-5000 employees

Answer: Gan & Lee Pharmaceuticals is in Pharmaceuticals

Answer: Gan & Lee Pharmaceuticals contact info: Phone number: Website: https://ganlee.com

Answer: Founded in 1998, Gan & Lee Pharmaceuticals has successfully developed the first Chinese domestic insulin analog. The company has become one of the main suppliers of insulin in China and now strives to broaden its global coverage in the field of diabetes diagnosis and treatment. Headquartered in the Tongzhou Economic Development Area, Beijing, China, Gan & Lee has state-of-the-art buildings and GMP facilities. In 2014, it established a US subsidiary in New Jersey, and in 2019, Gan & Lee selected Linyi City, Shandong, China, to become its second domestic drug production site, with further plans to expand to North America, Europe, and other regions. Gan & Lee is committed to providing solutions to patients across the globe and providing a positive impact on patient lives. Our clinical development program is investigating new chemical entities and biologics to treat cardiovascular disease, metabolic disease, cancer and diseases in other therapeutic areas.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access